The complex process of neutrophil activation and accumulation is orchestrated by a cascade of cytokines and bioactive lipids produced at the site of inflammation. Neutrophils are a rich source of the potent inflammatory lipid leukotriene B,(LTB,).
Granulocyte-macrophage colony-stimulating factor (GM-CSF) can activate neutrophils for an exponential increase in LTB, production in response t o a number of subsequent stimuli. In this report, we examined the temporal regulation, by GM-CSF, of the gene and protein expression of 5-lipoxygenase (5-LOX1, a key enzyme of the LTB, production pathway. Human neutrophils were exposed t o l 0 n g l mL of GM-CSF for various periods of time and 5-LOX mRNA was measured by Northern blot analysis. We observed no change in 5-LOX mRNA at early time points (0.25 t o 3 hours); however, by 18 hours we observed a significant augmentation of 5-LOX-specific message (4.3-f 1.7-fold increase; n = 6). Nuclear transcription assays indicated that the rate of 5-LOX gene transcription was augmented threefold in neutrophils incubated with GM-CSF, whereas the half-life of the message was not markedly changed. Parallel experi-
ELLS OF MYELOID ORIGIN, including granulocytes,
are a rich source of leukotriene B4 (LTB4), which is a potent promoter of many physiologic and inflammatory events such as neutrophil adhesion to the vessel wall, chemotaxis, aggregation and degran~lation.l-~ In addition, LTB4 possesses a synergistic stimulatory effect on granulocytemacrophage colony-stimulating factor (GM-CSF)-induced myeloid progenitor cell g r o~t h .~.~ Whereas resting neutrophils produce relatively low amounts of this bioactive lipid, they can be activated by selected cytokines, such as GM-CSF, for an exponential increase in arachidonic acid release, 20-COOH LTB,, 20-OH LTB4, 5-HETE, and LTB, production.'"' LTB, has been shown to modulate many functions of other cell populations: it can stimulate interferon y (IFNy) production by T cells,'* interleukin-6 (IL-6) and tumor necrosis factor a (TNFm) production by monocytes and alveolar macrophage^,""^ IL-2 receptor a and /3 chain expression on monocytes,I6 and IL-2RP expression on natural killer (NK) cells," thus enhancing their responsiveness to IL-2. The sustained production of LTB4 by neutrophils may thus perpetuate the inflammatory reaction by activating several cell types.
Stimulation of neutrophils with GM-CSF is associated with the release of free arachidonic acid from internal pools and its subsequent metabolism through the 5-lipoxygenase (5-LOX) pathway. S-LOX has been purified and cloned from several sources including human neutrophils.'8,'9 Depending on the cell type, S-LOX protein is found in the cytosol or nucleus.*" The activation of the 5-LOX system is dependent on substrate (arachidonic acid) availability, Ca", ATP, and other undefined stimulatory factors.".'* Upon cell activation, the S-LOX is translocated to the nuclear membrane in a Ca2'-dependent manner, where it is associated with the 5-LOX-activating protein A recent study of 5-LOX-deficient mice, produced by gene disruption of 5-LOX, provides unequivocal evidence for its role in LT pro- ments indicated that the levels of 5-LOX protein were also increased by GM-CSF. The augmentation was observed within 30 minutes after stimulation and was maximal (5.23 ? 2.6; n = 4) at 18 hours. Incubation of GM-CSF-stimulated neutrophils with protein synthesis inhibitors resulted in a time-dependent impairment of their ability t o produce LTB,, with no inhibition seen during the first hours, a 75% decrease seen by 12 hours, and greater than 95% inhibition seen at 18 hours. Collectively, our data imply that GM-CSF can regulate LTB, production by two distinct mechanisms: a short-term increase that is not related t o increased 5-LOX mRNA expression and is independent of protein synthesis, and a sustained increase in LTB, production that is associated with the transcriptional activation of the 5-LOX gene, increase in 5-LOX mRNA levels, and dependence on protein synthesis. Such transcriptional modulation of 5-LOX enzyme expression may provide new approaches for therapeutic intervention in protracted inflammatory conditions. 0 1995 by The American Society of Hematology.
duction and the involvement of LTs in defined inflammatory reaction^.'^ Despite accumulating information on the mechanisms that control the activation of 5-L0X, little is known on the modulation of 5-LOX gene expression and protein levels in LTproducing cells. A recent report has shown that short-term exposure to GM-CSF increases 5-LOX protein synthesis in neutrophils.*6 In this report, we present evidence that longterm incubation of human neutrophils with GM-CSF upregulates 5-LOX gene transcription and mRNA levels. Our data suggest that exposure of neutrophils to GM-CSF for prolonged periods of time (2 to 18 hours) maintains augmented production of LTs by these cells. The prolonged LT production may provide a source of LTB4 for activation of other cell populations recruited into the inflammatory site. This long-term production can be modulated at the pretranslational level and may thus provide new venues for therapeutic intervention. To assess stability of S-LOX mRNA, cells were treated with Actinomycin D (1 yg/mL) 18 hours after stimulation with GM-CSF or medium to arrest transcription. The incubation was then stopped at various time intervals and Northern analysis was performed as mentioned above.
MATERIALS AND METHODS

Preperation
Signal intensity was quantitated by densitometry with a Lightning Scan (Pro 256; Thunderware, Orinda, CA) and analyzed with Scan Analysis 2.21 for the Macintosh (Biosoft, Cambridge, UK).
In vitro nuclear trunscription. The in vitro nuclear transcription assays were performed according to the method of Greenberg and Bender," with several modifications. Briefly, nuclei were prepared from human neutrophils by resuspending cells in a lysis buffer con-
nol, and 0.1% Nonidet P-40 (NP-40). followed by sedimentation through a 30% sucrose solution. In vitro transcription was performed in the following transcription mixture: buffer 100 mrnolk GTP, 100 mmoIlL ATP. 100 mmol/L CTP in the presence of [a-"P] UTP (>600 Ci/mmol). The radiolabeled RNA was isolated by chloroform/phenol extraction and trichloroacetic acidsodium pyrophosphate precipitation. The labeled nuclear RNA was then hybridized to linearized cDNA probes that were immobilized on Genescreen plus membranes with a slot blot apparatus. The membranes were prehybridized for 2 days with the following mixture: SO m m o l n HEPES, pH 7.5, 0.75 mol/L NaCI, 50% formamide, O S % sodium dodecyl sulfate (SDS), 2 mmol/L EDTA, lox Denhart's solution, 500 yg/mL salmon sperm DNA, and 10 yg/mL poly A. Hybridization was performed for 4 days in the same mixture with the radiolabeled RNA. The membranes were then washed and exposed to x-ray film for 2 weeks Western blotting. Protein extracts were prepared as previously described.'> Briefly, cells were lysed in the presence of 1% NP-40 and l mmol/L PMSF (Sigma). The extracts were cleared by centrifugation at 10,OOOg for I hour. Twenty micrograms of protein per lane were separated on a 12% SDS-polyacrylamide gel (SDS-PAGE) and electroblotted onto nitrocellulose (RioRad Trans-Blot electrophoretic transfer cell). After transfer, nonspecific sites on the membrane were blocked with 3% milk proteins for l to 4 hours and incubated overnight in the presence of 1:250 final dilution of 5-LOX or FLAP polyclonal antiserum."^" The membranes were then washed four times and the immunoreactive bands were shown using the chemiluminescence detection system (ECL; Amersham) or 0.5 pCi/mL "'I-protein A (Dupont-New England Nuclear, Mississauga, Ontario, Canada) as indicated in the legend.
RESULTS
GM-CSF augments S-LOX mRNA expression.
We examined the modulation of 5-LOX mRNA accumulation after treatment with GM-CSF. Total cellular RNA was obtained and probed for 5-LOX-specific message. As shown in Fig  I , the S-LOX mRNA level was not modulated at early time points, but was increased up to 9.5-fold at 18 hours. The observed increase ranged between 2.0-and 9.5-fold (mean 4.3-2 1.7-fold; n = 6), depending on the individual donor.
GM-CSF does not affect the decay of S-LOX mRNA expression. To determine whether the augmented 5-LOX mRNA accumulation seen at 18 hours resulted from a transcriptional or posttranscriptional mechanism, we first examined whether GM-CSF modulated 5-LOX mRNA stability. For this, polymorphonuclear leukocytes (PMN) were preincubated with GM-CSF for 18 hours, Actinomycin D was added, and 5-LOX mRNA accumulation was measured at the indicated times. as shown in Fig 2 . In control cells, the level of 5-LOX mRNA progressively declined during Actinomycin D treatment, with a half-life of 4 hours and 30 minutes. Treatment of the cells with GM-CSF resulted in a similar mRNA decay rate, with a calculated half-life of 4 hours and 45 minutes. Thus, GM-CSF did not appreciably change 5-LOX mRNA stability.
GM-CSF stimulates 5-LOX transcriptional activity. We used in vitro nuclear transcription experiments to examine the effect of GM-CSF on the transcriptional activity of the 5-LOX gene. Because the transcriptional activity of PMN is extremely low, high numbers of cells (2.25 X 10') were used for each determination. Results from a representative experiment indicate that stimulation of neutrophils with GM-CSF resulted in a threefold increase (3.7--+ 0.63-fold; n = 4) i n 5-LOX transcriptional activity (Fig 3) . These data suggest that a significant portion of GM-CSF-induced regulation of S-LOX message is at the transcriptional level.
GM-CSF induces a sustained increase in S-LOX protein expression. We next examined the effect of GM-CSF on S-LOX protein expression. Neutrophils were incubated with 10 ng/mL of GM-CSF and SDS-PAGE-separated cellular proteins were analyzed with polyclonal anti-5-LOX antiserum. 5-LOX protein expression was increased threefold (2.5-2 0.34-fold; n = 4) after 30 minutes in the presence of GM- on GM-CSF-irltllrc~~tl LTU, prorlrcction. We used protein synthesis inhibitors t o determine whether the augmented protein expression was essential for the GM-CSF-induced increase in LTB, production. PMN were treated with cycloheximide ( I O pglrnL) for 30 minutes before stimulation with GM-CSF. The cells were then incubated for various periods o f time and LTB, production was determined. Incubation o f GM-CSF-stimulated neutrophils with cycloheximide resulted in a time-dependent impairnment in their ability to produce LTR., in response t o the ionophore A23187: no decrease was seen before 8 hours. with a 75% blockage seen by 12 hours and greater than 95% inhibition seen at 18 hours (Fig SA) . The inhibitory effect ofcyclohexinlide on GM-CSF-primed LTR, production could he shown at 18 hours (Fig SC) but not at 2 hours (Fig SB) in the presence of a l l concentrations of GM-CSF used. Similar results were obtained with higher concentration of cyclohexi- Fig 4) . whereas cycloheximide treatment did block the increase in immunoreactive S-LOX seen after 18 hours of incubation with GM-CSF (Fig 4) .
GM-CSF is a multifunctional cytokine that has : I primary role a s a hematopoietic growth factor. In nddition, it can directly activate and have a priming effect o n mature phagocytes.'"'" Despite much interest in the mechanism(s) by which GM-CSF could affect secondary responses to an ngo- not been examined. In this report, we show that neutrophils exposed to GM-CSF for 18 hours and challenged with the ionophore A23 I87 produced significantly more LTB4 than cells unexposed to GM-CSF. We observed that the shortterm increase in GM-CSF-induced LTBJ production is not temporally related to changes in S-LOX mRNA levels and is independent of protein synthesis. In contrast, the longterm augmentation of LTB4 production is associated with augmented S-LOX gene transcription rate and increased S-LOX mRNA expression and is dependent on protein synthesis.
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By Western blotting of total cellular proteins, we observed that GM-CSF augmented the levels of S-LOX protein within IS to 30 minutes. which correlated well with the reported time frame for optimal GM-CSF priming effect.'"," Such early increase in protein expression is not temporally related to changes in 5-LOX mRNA level that occur at a later time (26 hours) after stimulation and is then presumably a result of translational events. Supporting this. a recent report from Pouliot et al'" has shown a rapid (30 minutes) augmentation of de novo synthesis of 5-LOX protein in neutrophils stimulated with GM-CSF. In parallel to our study, they have not observed any changes in the level of S-LOX mRNA during the time frame studied ( 1 S to 60 minutes). The increase in the rate of S-LOX translation might be caused by modification o f regulatory controls of translation by GM-CSF. eg, modulation of initiation and elongation factors."
Treatment of neutrophils with protein synthesis inhibitors, for up to 8 hours, did not diminish the effect of GM-CSF on LTB, production, whereas, in parallel experiments, the increase in S-LOX protein was abolished by this treatment. These data indicate that early increase in S-LOX protein level is not related to the observed augmentation in LTB, production. This finding is in agreement with other studies that show that short-term GM-CSF-induced LTB, production was independent of protein synthesis."'.3H In contrast, one report has observed inhibition of GM-CSF-induced priming of S-LOX activity by cycloheximide and Actinomycin D."' The reason for this discrepancy is, for the moment, unclear. In our study, the effect of GM-CSF on other components of the enzymatic and signal-transduction cascade leading to LTB4 production might account for its short-term effect. It has been suggested that short-term priming might be caused by an enhanced signal transduction'""" or increased S-LOX enzyme activity, as has been described for the PLA2 enzyme."
The dissociation between protein synthesis and LTB, production might have important physiologic consequences at the time of acute inflammation. During myeloid diffcrcntiation, the level of 5-LOX increases and is maximal when the neutrophils are fully differentiated and have the ability to play an effector role in host defense mechanisms.J5 For example, in acute inflammation, neutrophils are rapidly recruited to a local inflammatory site where they can be rapidly primed by cytokines, such as GM-CSF, for a resulting exponential increase in LTB, production. This process would be needed for rapid clearance of the inflammatory site and cannot be impeded by the necessity for a slower mode of activation requiring de novo protein synthesis. 
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Long-term incubation of neutrophils in the presence of GM-CSF maintained their augmented LTB4 production, when compared with control cells. This sustained increase of LTB, production correlated with increased 5-LOX mRNA expression and, in contrast to short-term GM-CSF treatment, was dependent on protein synthesis. The viability and functionality of cycloheximide-treated cells was similar to that of control cells and thus increased cell death could not account for the differences in response by the two populations. Also, cycloheximide used at the same concentration did not significantly affect the levels of immunoreactive 5-LOX and FLAP proteins in control PMN over the 18-hour time period examined, whereas cycloheximide treatment blocked the increase in immunoreactive 5-LOX seen after 18 hours of incubation with GM-CSF. This finding is in agreement with studies showing that the turnover of these two proteins is The putative promoter region of the 5-LOX gene presents similarities with housekeeping gene promoters that would suggest a constitutive nature of expres~ion.~~ In this study, results from run-on analysis provide, for the first time, direct evidence that 5-LOX gene transcriptional activity can be enhanced by GM-CSF. These data suggest that cellular 5-LOX pools might be subject to environmental regulatory factors. GM-CSF has been reported to protect PMN from undergoing apoptosis, therefore prolonging survival and accumulation in the ti~sue.4~ Considering the suicidal nature of the 5-L0X,'0 the increase in 5-LOX transcriptional activity, which follows sustained exposure to GM-CSF, is likely to be crucial to replenish the pools of 5-LOX that might have been depleted during initial response to agonists. Therefore, GM-CSF not only prolongs PMN longevity but could also stimulate the replenishment of enzymatic proteins needed for subsequent challenges and thereby sustained LT production. This possibility is currently under investigation. Moreover, whereas the early increase in LTB, production may be needed for further recruitment of PMN, the late phase enhancement of LTB, production may contribute to activation of other cell populations that migrate into the inflammatory site at later times.
Neutrophils are a major source of the bioactive lipid LTBI that plays a role in acute and chronic inflammatory processes, acting as a chemoattractant and as a cofactor or direct stimulus in inflammatory cytokine These cytokines can, in turn, modulate the production of lipid mediators, including LTB4, from various cell types present at the site*ll.s'.s3 LTs have been implicated in several pathologic states, such as inflammatory bowel disease, gout, rheumatoid arthritis, allergy, and asthmg""; thus, the definition of the regulation of this pathway would indicate possible sites for intervention. The present findings are the first demonstration that GM-CSF upregulates 5-LOX gene expression. Our data suggest that GM-CSF can increase the level of LTB4 production through both an early-phase and a late-phase regulatory mechanism. Whereas the former depends on the activation of preformed pools of 5-L0X, the latter requires specific activation of PMN gene expression that may provide new approaches to the control of chronic LT synthesis in disease states. For personal use only. on August 30, 2017 . by guest www.bloodjournal.org From
